ETHZilla Corp — Director's Dealing 2024

Dec 31, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2024-12-27

Reporting Person: ELRAY RESOURCES, INC. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Convertible Preferred Stock	$		Common Stock (1318000)		Direct
Common Stock Purchase Warrants	$1.68	2031-09-30	Common Stock (3000000)		Direct

Footnotes

F1: The conversion of the Series B Convertible Preferred Stock and exercise of the warrants was subject to shareholder approval, which shareholder approval was received on December 27, 2024.

F2: The Series B Convertible Preferred Stock has no expiration date. The Series B Convertible Preferred Stock is described in greater detail in the Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on October 3, 2024.

F3: Each of the 1,000,000 shares of Series B Convertible Preferred Stock is convertible into 1.318 shares of common stock.